UBS Group AG - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$315,845
-55.9%
17,586
-50.0%
0.00%
Q2 2023$715,907
+838.9%
35,197
+904.5%
0.00%
Q1 2023$76,247
-95.2%
3,504
-93.2%
0.00%
-100.0%
Q4 2022$1,605,003
+487.9%
51,791
+384.3%
0.00%
Q3 2022$273,000
-39.2%
10,694
-51.7%
0.00%
Q2 2022$449,000
-62.1%
22,125
-53.8%
0.00%
Q1 2022$1,186,000
+28.5%
47,941
+80.5%
0.00%
Q4 2021$923,000
+21.8%
26,566
-5.0%
0.00%
Q3 2021$758,000
+501.6%
27,961
+476.6%
0.00%
Q2 2021$126,000
-86.1%
4,849
-88.5%
0.00%
Q1 2021$905,000
+2413.9%
41,990
+2444.8%
0.00%
Q4 2020$36,000
+414.3%
1,650
+239.5%
0.00%
Q3 2020$7,000
-56.2%
486
-31.2%
0.00%
Q2 2020$16,000
+33.3%
706
-17.3%
0.00%
Q1 2020$12,000
-47.8%
854
-38.9%
0.00%
Q4 2019$23,000
-98.2%
1,397
-96.2%
0.00%
-100.0%
Q3 2019$1,303,000
+21.1%
37,225
+95.4%
0.00%
Q2 2019$1,076,000
+218.3%
19,055
+312.3%
0.00%
Q1 2019$338,000
-86.5%
4,622
-88.3%
0.00%
-100.0%
Q4 2018$2,513,000
+74.8%
39,384
+173.2%
0.00%0.0%
Q3 2018$1,438,000
+470.6%
14,415
+307.0%
0.00%
Q2 2018$252,000
-95.0%
3,542
-92.8%
0.00%
-100.0%
Q1 2018$5,087,000
+227.6%
48,878
+217.0%
0.00%
+100.0%
Q4 2017$1,553,000
+1484.7%
15,417
+450.0%
0.00%
Q3 2017$98,000
+22.5%
2,803
-16.4%
0.00%
Q2 2017$80,000
+2566.7%
3,351
+2865.5%
0.00%
Q1 2017$3,0001130.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders